Yayın: Baseline alt levels but not HDV-RNA levels are associated with response to pegylated interferon ALFA-2a treatment of delta hepatitis: Data from the HIDIT-1 trial
| dc.contributor.author | Wedemeyer, Heiner | |
| dc.contributor.author | Yurdaydın, Cihan | |
| dc.contributor.author | Zachou, Kalliopi | |
| dc.contributor.author | Erhardi, Annette | |
| dc.contributor.author | Çakaloğlu, Yılmaz | |
| dc.contributor.author | Yalçın, Kendal | |
| dc.contributor.author | Gürel, Selim | |
| dc.contributor.author | Zeuzem, Stefan | |
| dc.contributor.author | Bozkaya, Hakan | |
| dc.contributor.author | Dalekos, George N. | |
| dc.contributor.author | Manns, Michael P. | |
| dc.contributor.buuauthor | GÜREL, SELİM | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.researcherid | HLH-8209-2023 | |
| dc.date.accessioned | 2024-11-13T05:17:31Z | |
| dc.date.available | 2024-11-13T05:17:31Z | |
| dc.date.issued | 2008-10-01 | |
| dc.description | Bu çalışma, Ekim 31-Kasım 04, 2008 tarihlerinde San Francisco[Amerika]’da düzenlenen 59. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases Kongresi‘nde bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | Amer Assoc Study Liver Dis | |
| dc.description.sponsorship | Moscone West Convent Ctr | |
| dc.identifier.endpage | 714A | |
| dc.identifier.issn | 0270-9139 | |
| dc.identifier.issue | 4, Supplement S | |
| dc.identifier.startpage | 713A | |
| dc.identifier.uri | https://hdl.handle.net/11452/47799 | |
| dc.identifier.volume | 48 | |
| dc.identifier.wos | 000259757401292 | |
| dc.indexed.wos | WOS.SCI | |
| dc.indexed.wos | WOS.ISTP | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.journal | Hepatology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Gastroenterology & hepatology | |
| dc.title | Baseline alt levels but not HDV-RNA levels are associated with response to pegylated interferon ALFA-2a treatment of delta hepatitis: Data from the HIDIT-1 trial | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi | |
| local.indexed.at | WOS | |
| relation.isAuthorOfPublication | d7a9ea11-69fc-4122-a365-8fb2123512e6 | |
| relation.isAuthorOfPublication.latestForDiscovery | d7a9ea11-69fc-4122-a365-8fb2123512e6 |
